Total submissions: 18
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000037889 | SCV000051516 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000037889 | SCV000061551 | benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | p.Arg71Gln in Exon 02 of BAG3: This variant is not expected to have clinical sig nificance because it has been identified in 3.4% (237/7020) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs35434411). |
Gene |
RCV000037889 | SCV000167152 | benign | not specified | 2014-01-22 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000228853 | SCV000288302 | benign | Myofibrillar myopathy 6; Dilated cardiomyopathy 1HH | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000037889 | SCV000310052 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000248400 | SCV000318146 | benign | Cardiovascular phenotype | 2015-06-19 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV000576846 | SCV000360554 | benign | Myofibrillar myopathy 6 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000283994 | SCV000360555 | likely benign | Dilated cardiomyopathy 1HH | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
ARUP Laboratories, |
RCV000588408 | SCV000602620 | benign | not provided | 2023-11-09 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000576846 | SCV000677140 | benign | Myofibrillar myopathy 6 | 2017-06-02 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000588408 | SCV000698278 | benign | not provided | 2017-08-16 | criteria provided, single submitter | clinical testing | Variant summary: The BAG3 c.212G>A (p.Arg71Gln) variant involves the alteration of a non-conserved nucleotide. 4/4 in silico tools predict a benign outcome for this variant (SNPsandGO not captured due to low reliability index). This variant was found in 2442/121378 control chromosomes (35 homozygotes) at a frequency of 0.020119, which is approximately 515 times the estimated maximal expected allele frequency of a pathogenic BAG3 variant (0.0000391), suggesting this variant is likely a benign polymorphism. In addition, multiple clinical diagnostic laboratories/reputable databases in ClinVar have classified this variant as benign. To our knowledge, this variant t has not been reported in affected individuals via publications, nor has it been evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as benign. |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000037889 | SCV000740455 | benign | not specified | 2016-08-01 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000037889 | SCV000858363 | benign | not specified | 2017-12-11 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003486564 | SCV004239680 | benign | Cardiomyopathy | 2022-11-14 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000588408 | SCV001741340 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000037889 | SCV001925782 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000588408 | SCV001930403 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000037889 | SCV001955896 | benign | not specified | no assertion criteria provided | clinical testing |